Author: Ying Huang; Rui Yang; Ying Xu; Ping Gong
Title: Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China Document date: 2020_2_29
ID: 9hh17k86_8
Snippet: Lots of patients died from COVID-19 till now. The median survival time of these non-survivors from onset to death was about 2 weeks. Most patients were older males with comorbidities. They finally progressed to ARDS. The median time from onset to ARDS was 11 days. Gradually decreased lymphocytes and increased inflammation biomarkers were common, and need to be monitored in the routine treatment......
Document: Lots of patients died from COVID-19 till now. The median survival time of these non-survivors from onset to death was about 2 weeks. Most patients were older males with comorbidities. They finally progressed to ARDS. The median time from onset to ARDS was 11 days. Gradually decreased lymphocytes and increased inflammation biomarkers were common, and need to be monitored in the routine treatment.
Search related documents:
Co phrase search for related documents- ARDS onset median time and routine treatment: 1
- ARDS onset median time and survival time: 1
- ARDS progress and median time: 1
- ARDS progress and old male: 1, 2, 3, 4, 5, 6
- inflammation biomarker and median time: 1
- median time and old male: 1, 2, 3, 4, 5, 6, 7
- median time and routine treatment: 1, 2, 3, 4, 5, 6, 7, 8
- median time and survival time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- old male and patient lot: 1
- old male and routine treatment: 1, 2, 3
- old male and survival time: 1, 2, 3
- routine treatment and survival time: 1, 2
Co phrase search for related documents, hyperlinks ordered by date